Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raphael Itzykson

Showing results (21-30 of 97) with videos related to

Pageof 10
Sort By:
Cytometry. Part B, Clinical Cytometry|April 10, 2019
The fraction of CD117/c-KIT-expressing erythroid precursors predicts ESA response in low-risk myelodysplastic syndromesAnna Raimbault, Raphael Itzykson, Lise Willems, et al.
Haematologica|September 28, 2014
Cytomegalovirus shapes long-term immune reconstitution after allogeneic stem cell transplantationRaphael Itzykson, Marie Robin, Helene Moins-Teisserenc, et al.
Annals of Hematology|February 11, 2023
Benefits of dexamethasone on early outcomes in patients with acute myeloid leukemia with hyperleukocytosis: a propensity score matched analysisMarco Cerrano, Sylvie Chevret, Emmanuel Raffoux, et al.
Journal of Internal Medicine|July 10, 2023
Novel precision medicine approaches and treatment strategies in hematological malignanciesRichard Rosenquist, Elsa Bernard, Tom Erkers, et al.
American Journal of Hematology|September 9, 2014
Molecular and prognostic correlates of cytogenetic abnormalities in chronic myelomonocytic leukemia: a Mayo Clinic-French Consortium StudyEmnet A Wassie, Raphael Itzykson, Terra L Lasho, et al.
Blood|November 7, 2024
Perspectives on drug development in chronic myelomonocytic leukemia: changing the paradigmAnthony M Hunter, Mrinal M Patnaik, Raphael Itzykson, et al.
Leukemia Research|March 19, 2013
Azacitidine in the treatment of therapy related myelodysplastic syndrome and acute myeloid leukemia (tMDS/AML): a report on 54 patients by the Groupe Francophone Des Myelodysplasies (GFM)Cecile Bally, Sylvain Thépot, Bruno Quesnel, et al.
NAR Genomics and Bioinformatics|May 27, 2024
PitViper: a software for comparative meta-analysis and annotation of functional screening dataPaul-Arthur Meslin, Lois M Kelly, Salima Benbarche, et al.
Plos One|July 7, 2022
Post-remission outcomes in AML patients with high hyperleukocytosis and inaugural life-threatening complicationsSofiane Fodil, Sylvie Chevret, Camille Rouzaud, et al.
Leukemia Research|February 19, 2013
Predictive factors of response and survival among chronic myelomonocytic leukemia patients treated with azacitidineLionel Adès, Mikkael A Sekeres, Alice Wolfromm, et al.
Pageof 10

Showing results (21-30 of 97) with videos related to

Sort By:
Pageof 10
Cytometry. Part B, Clinical Cytometry|April 10, 2019
The fraction of CD117/c-KIT-expressing erythroid precursors predicts ESA response in low-risk myelodysplastic syndromesAnna Raimbault, Raphael Itzykson, Lise Willems, et al.
Haematologica|September 28, 2014
Cytomegalovirus shapes long-term immune reconstitution after allogeneic stem cell transplantationRaphael Itzykson, Marie Robin, Helene Moins-Teisserenc, et al.
Annals of Hematology|February 11, 2023
Benefits of dexamethasone on early outcomes in patients with acute myeloid leukemia with hyperleukocytosis: a propensity score matched analysisMarco Cerrano, Sylvie Chevret, Emmanuel Raffoux, et al.
Journal of Internal Medicine|July 10, 2023
Novel precision medicine approaches and treatment strategies in hematological malignanciesRichard Rosenquist, Elsa Bernard, Tom Erkers, et al.
American Journal of Hematology|September 9, 2014
Molecular and prognostic correlates of cytogenetic abnormalities in chronic myelomonocytic leukemia: a Mayo Clinic-French Consortium StudyEmnet A Wassie, Raphael Itzykson, Terra L Lasho, et al.
Blood|November 7, 2024
Perspectives on drug development in chronic myelomonocytic leukemia: changing the paradigmAnthony M Hunter, Mrinal M Patnaik, Raphael Itzykson, et al.
Leukemia Research|March 19, 2013
Azacitidine in the treatment of therapy related myelodysplastic syndrome and acute myeloid leukemia (tMDS/AML): a report on 54 patients by the Groupe Francophone Des Myelodysplasies (GFM)Cecile Bally, Sylvain Thépot, Bruno Quesnel, et al.
NAR Genomics and Bioinformatics|May 27, 2024
PitViper: a software for comparative meta-analysis and annotation of functional screening dataPaul-Arthur Meslin, Lois M Kelly, Salima Benbarche, et al.
Plos One|July 7, 2022
Post-remission outcomes in AML patients with high hyperleukocytosis and inaugural life-threatening complicationsSofiane Fodil, Sylvie Chevret, Camille Rouzaud, et al.
Leukemia Research|February 19, 2013
Predictive factors of response and survival among chronic myelomonocytic leukemia patients treated with azacitidineLionel Adès, Mikkael A Sekeres, Alice Wolfromm, et al.
Pageof 10